Varoxo 10/15/20 10 mg, 15 mg, 20 mg Tablets

Varoxo 10/15/20 10 mg, 15 mg, 20 mg Tablets

S4
PDF Leaflet Revision Date: 26 March 2025

API: Rivaroxaban | Company: Adcock Ingram

Clinical Summary

Quick overview from the medicine insert

Indication

Prevention and treatment of thromboembolic events.

Dosage (summary)

VAROXO 10: 10 mg once daily; VAROXO 15: 15 mg once daily; VAROXO 20: 20 mg once daily.

Special Populations

  • Hepatic impairment
  • Renal impairment
  • Elderly

Pregnancy & Breastfeeding

Contraindicated in pregnancy and lactation.

Key Drug Interactions

  • Strong CYP3A4 and P-gp inhibitors
  • NSAIDs
  • Warfarin

Contraindications

  • Active bleeding
  • Severe hepatic disease
  • Hypersensitivity to rivaroxaban

Common side effects

  • Bleeding
  • Anaemia
  • Dizziness

Counselling Points

  • Monitor for signs of bleeding
  • Take with food for VAROXO 15 and 20
  • Use effective contraception in women of childbearing potential

Serious warnings

  • Increased risk of thrombotic events with premature discontinuation
  • Risk of spinal/epidural haematoma
Important Disclaimer

The Varoxo 10/15/20 10 mg, 15 mg, 20 mg Tablets professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites